![Tetsuya Fujimori](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tetsuya Fujimori
Directeur/Bestuurslid bij Cenegenics Japan KK
Actieve functies van Tetsuya Fujimori
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Cenegenics Japan KK
![]() Cenegenics Japan KK Medical SpecialtiesHealth Technology Cenegenics Japan KK engages in the advanced medical support business using genes, cells, and tissues. The company was founded on March 23, 2020 and is headquartered in Tokyo, Japan. | Directeur/Bestuurslid | 01-03-2020 | - |
Loopbaan van Tetsuya Fujimori
Eerdere bekende functies van Tetsuya Fujimori
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
TELLA, INC. | Directeur/Bestuurslid | 25-03-2020 | - |
Independent Dir/Board Member | 25-03-2020 | - |
Opleiding van Tetsuya Fujimori
Osaka City University | Undergraduate Degree |
Statistieken
Internationaal
Japan | 4 |
Operationeel
Director/Board Member | 2 |
Independent Dir/Board Member | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
tella, Inc.
![]() tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
Cenegenics Japan KK
![]() Cenegenics Japan KK Medical SpecialtiesHealth Technology Cenegenics Japan KK engages in the advanced medical support business using genes, cells, and tissues. The company was founded on March 23, 2020 and is headquartered in Tokyo, Japan. | Health Technology |
- Beurs
- Insiders
- Tetsuya Fujimori
- Ervaring